Envoy Medical, Inc.

COCH

COCHEnvoy Medical, Inc. US flag

NASDAQ Capital Market

0.69

USD

-0.02

- -

14.32MMarket Cap

Income Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -
- Cost of Revenue	1	- -	1	1	1
+ Cost of Goods & Services	1	- -	1	1	1
Gross Profit	- -	- -	- -	-1	-1
+ Other Operating Income	- -	- -	- -	- -	- -
- Operating Expenses	6	8	18	19	22
+ Selling, General & Admin	2	3	9	9	9
+ Research & Development	4	5	9	10	12
+ Other Operating Expense	- -	- -	- -	- -	- -
Operating Income (Loss)	-7	-9	-18	-19	-22
- Non-Operating (Income) Loss	2	7	12	2	1
+ Interest Expense, Net	- -	- -	- -	1	2
+ Interest Expense	- -	- -	- -	1	2
- Interest Income	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	2	7	12	1	- -
Pretax Income	-9	-16	-30	-21	-24
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-9	-16	-30	-21	-24
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-9	-16	-30	-21	-24
- Minority Interest	- -	- -	- -	- -	- -
Net Income, GAAP	-9	-16	-30	-21	-24
- Preferred Dividends	2	2	1	6	5
- Other Adjustments	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-11	-18	-31	-26	-29
EBIT	-7	-9	-18	-19	-22
EBITDA	-7	-9	-18	-19	-22
EBITDA Margin (%)	-2,193.55	-3,641.77	-5,767.72	-8,481.33	-9,115.35
EBITA	-7	-9	-18	-19	-22
Gross Margin (%)	-148.06	-110.13	-149.68	-229.78	-262.66
Operating Margin (%)	-2,216.45	-3,673.42	-5,809.81	-8,558.22	-9,240.66
Profit Margin (%)	-2,798.39	-6,718.57	-9,468.99	-9,242.22	-9,857.26
Sales per Employee	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	0.13	- -
Depreciation Expense	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	10	10	12	19	- -
Basic EPS, GAAP	-1.05	-1.77	-2.54	-1.4	- -
Basic EPS from Cont Ops	-0.85	-1.57	-2.43	-1.11	- -
Diluted Weighted Avg Shares	10	10	12	19	- -
Diluted EPS, GAAP	-1.05	-1.77	-2.54	-1.4	- -
Diluted EPS from Cont Ops	-0.85	-1.57	-2.43	-1.11	- -

Balance Sheet (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	2	2	7	9	6
+ Cash, Cash Equivalents & STI	1	- -	4	5	4
+ Cash & Cash Equivalents	1	- -	4	5	4
+ ST Investments	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	1	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	1	- -
+ Inventories	1	1	1	2	2
+ Raw Materials	1	1	1	1	1
+ Work In Process	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	2	1	1
+ Misc ST Assets	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	1	1	3	2
+ Property, Plant & Equip, Net	- -	-4	1	2	2
+ Property, Plant & Equip	5	1	5	7	7
- Accumulated Depreciation	4	5	5	5	5
+ LT Investments & Receivables	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -
+ Other LT Assets	- -	5	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	5	- -	- -	- -
Total Assets	3	3	8	12	9
+ Payables & Accruals	1	2	6	6	11
+ Accounts Payable	1	1	2	2	3
+ Accrued Taxes	- -	- -	- -	- -	2
+ Interest & Dividends Payable	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	1	5	4	6
+ ST Debt	- -	1	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	1	1	1
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	1	1	1
Total Current Liabilities	1	3	7	8	12
+ LT Debt	23	34	- -	20	1
+ LT Borrowings	23	33	- -	19	- -
+ LT Finance Leases	- -	1	- -	1	1
+ Other LT Liabilities	23	2	2	3	8
+ Accrued Liabilities	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Misc LT Liabilities	23	2	2	3	8
Total Noncurrent Liabilities	46	36	3	23	9
Total Liabilities	48	39	10	30	20
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -
+ Share Capital & APIC	165	190	256	266	301
+ Common Stock	1	- -	- -	- -	- -
+ Additional Paid in Capital	164	190	256	266	301
- Treasury Stock	- -	- -	- -	- -	- -
+ Retained Earnings	-210	-226	-257	-285	-313
+ Other Equity	- -	- -	- -	- -	- -
Equity Before Minority Interest	-45	-36	-2	-19	-12
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
Total Equity	-45	-36	-2	-19	-12
Total Liabilities & Equity	3	3	8	12	9
Shares Outstanding	20	20	20	21	29
Number of Employees	- -	- -	- -	- -	- -
Capital Leases - Total	- -	1	1	1	1
Net Debt	22	34	-4	13	-4
Net Debt to Equity	-49.72	-93	237.5	-70.23	31.78
Tangible Common Equity Ratio	-1,713.41	-1,416.08	-21.47	-163.3	-137.5
Current Ratio	1.76	0.65	1.02	1.18	0.54
Cash Conversion Cycle	- -	548.07	168.74	293.65	-437.91

Cash Flow Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-9	-16	-30	-21	-24
+ Depreciation & Amortization	- -	- -	- -	- -	- -
+ Non-Cash Items	2	7	14	3	3
+ Stock-Based Compensation	- -	- -	2	1	1
+ Deferred Income Taxes	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	2	7	12	3	3
+ Chg in Non-Cash Work Cap	- -	- -	-1	-1	2
+ (Inc) Dec in Accts Receiv	- -	- -	- -	-1	1
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-1	- -	- -
+ Inc (Dec) in Accts Payable	- -	- -	- -	- -	2
+ Inc (Dec) in Other	- -	-1	- -	1	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Operating Activities	-7	-9	-17	-18	-18
+ Change in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	-1	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	-1	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	2	7
+ Increase in Capital Stock	- -	- -	- -	2	7
+ Decrease in Capital Stock	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	-1	- -
+ Dividends Paid	- -	- -	- -	-2	-2
+ Net Cash From Debt	8	8	9	19	9
+ Cash From Debt	8	8	10	20	10
+ Repayments of Debt	- -	- -	-1	-1	-1
+ Other Financing Activities	- -	- -	12	2	2
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Financing Activities	8	8	21	20	17
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -
Net Changes in Cash	1	-1	4	1	-2
EBITDA	-7	-9	-18	-19	-22
EBITDA Margin (%)	-2,193.55	-3,641.77	-5,767.72	-8,481.33	-9,115.35
Free Cash Flow	-7	-9	-17	-19	-18
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-3	-9	-5	-14
Free Cash Flow per Basic Share	-0.7	-0.89	-1.4	-1.01	- -
Price/Free Cash Flow	-14.52	-11.85	-1.31	-1.58	- -
Cash Flow to Net Income	0.8	0.55	0.57	0.86	0.77
Capital Expenditures	- -	- -	- -	-1	- -